Stanford Medcast Episode 5: COVID-19 Mini-series - Immunomodulators Under Evaluation

Tuesday, October 20, 2020, 12:00 AM - Thursday, August 31, 2023, 11:59 PM

This episode will provide up to date insights about COVID-19 and treatments that target inflammation. Dr. Anne Liu will address the risk and benefits of using immunomodulators and when to use them based on the disease state of the patient. Listen in to learn how to treat patients early in the disease process with antivirals, and which immunomodulators are better and more cost effective for later stage disease.


AMA PRA Category 1 Credits™ (0.50 hours), Non-Physician Participation Credit (0.50 hours)

1. Evaluate current studies on the effectiveness of immunomodulators for the treatment of COVID-19.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

American Medical Association (AMA)

Stanford Medicine designates this Enduring Material for a maximum of 0.50 AMA PRA Category 1 Credits ^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

References

1. Felsenstein, S., Herbert, J.A., McNamara, P.S., & Hedrich, C.M. (2020). COVID-19: Immunology and treatment options. Clin Immunol, 215. https://doi.org/10.1016/j.clim.2020.108448

2. Yang, J.M., Koh, H.Y., Moon, S.Y., Yoo, I.K., Ha, E.K., You, S., (…), Lee, S.W. (2020). Allergic disorders and susceptibility to and severity of COVID-19: A nationwide cohort study. J Allergy Clin Immunol, 146:4, 790-798.

3. Yang, L., Liu, S., Liu, J., Zhang, Z., Wan, X., Huang, B., Chen, Y., & Zhang, Y. (2020). COVID-19: immunopathogenesis and Immunotherapeutics.  Sig Transduct Target Ther 5, 128. https://doi.org/10.1038/s41392-020-00243-2

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, please contact the CME Conference Coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: http://lane.stanford.edu/portals/cultural.html

For activity related questions, please contact
     Email: [email protected]

For CME general questions, please contact 
     Ph: (650)-497-8554
     Email: [email protected]

The Stanford University School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education.

There are no relevant financial relationships with ACCME-defined commercial interests for anyone who was in control of the content of this activity. 

This CME Activity is supported in part by educational grants from Novartis.